Acadia Healthcare Company COO Sells $119,472 in Stock (ACHC)
Acadia Healthcare Company (NASDAQ:ACHC) COO Ronald Morgan Fincher sold 2,489 shares of the stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $48.00, for a total value of $119,472.00. Following the transaction, the chief operating officer now directly owns 118,991 shares of the company’s stock, valued at approximately $5,711,568. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Acadia Healthcare Company (NASDAQ:ACHC) traded up 1.87% on Wednesday, hitting $48.49. 251,663 shares of the company’s stock traded hands. Acadia Healthcare Company has a 52-week low of $36.65 and a 52-week high of $53.87. The stock has a 50-day moving average of $47.04 and a 200-day moving average of $46.19. The company has a market cap of $2.900 billion and a price-to-earnings ratio of 39.14.
Acadia Healthcare Company (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $0.32 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.31 by $0.01. The company had revenue of $213.80 million for the quarter, compared to the consensus estimate of $207.73 million. During the same quarter in the prior year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 20.5% on a year-over-year basis. On average, analysts predict that Acadia Healthcare Company will post $1.46 earnings per share for the current fiscal year.
ACHC has been the subject of a number of recent research reports. Analysts at Zacks downgraded shares of Acadia Healthcare Company from an “outperform” rating to a “neutral” rating in a research note on Tuesday, August 5th. They now have a $53.00 price target on the stock. Separately, analysts at RBC Capital raised their price target on shares of Acadia Healthcare Company from $54.00 to $58.00 in a research note on Friday, August 1st. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Acadia Healthcare Company from $57.00 to $60.00 in a research note on Thursday, July 31st. They now have a “buy” rating on the stock. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Acadia Healthcare Company has a consensus rating of “Buy” and an average price target of $53.57.
Acadia Healthcare Company, Inc is a provider of inpatient behavioral healthcare services in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.